Abstract:Background: This study aimed to conduct a comparative analysis of the survival rates after segmentectomy, wedge resection, or lobectomy in patients with cStage IA lung squamous cell carcinoma (SCC). Methods: We enrolled 4,316 patients who had cStage IA lung SCC from the Surveillance, Epidemiology, and End Results (SEER) database. The Cox proportional hazards model was conducted to recognize the potential risk factors for overall survival (OS) and lung cancer-specific survival (LCSS). To eliminate potential biases of included patients, the propensity score matching (PSM) method was used. OS and LCSS rates were compared among three groups stratified according to tumor size. Results: Kaplan–Meier analyses revealed no statistical differences in the rates of OS and LCSS between wedge resection (WR) and segmentectomy (SG) groups for patients who had cStage IA cancers. In patients with tumors ≤ 1 cm, LCSS favored lobectomy (Lob) compared to segmentectomy (SG), but a similar survival rate was obtained for wedge resection (WR) and lobectomy (Lob). For patients with tumors sized 1.1 to 2 cm, lobectomy had improved OS and LCSS rates compared to the segmentectomy or wedge resection groups, with the exception of a similar OS rate for lobectomy and segmentectomy. For tumors sized 2.1 to 3 cm, lobectomy had a higher rate of OS or LCSS than wedge resection or segmentectomy, except that lobectomy conferred a similar LCSS rate compared to segmentectomy. Multivariable analyses showed that patients aged ≥75 and tumor sizes of >2 to ≤3 cm were potential risk factors for OS and LCSS, while lobectomy and first malignant primary indicator were considered protective factors. The Cox proportional analysis also confirmed that male patients aged ≥65 to <75 were independent prognostic factors that are indicative of a worse OS rate. Conclusions: The tumor size can influence the surgical procedure recommended for individuals with cStage IA lung SCC. For patients with tumors ≤1 cm, lobectomy is the recommended approach, and wedge resection or segmentectomy might be an alternative for those who cannot tolerate lobectomy if adequate surgical margin is achievable and enough nodes are sampled. For tumors >1 to ≤3 cm, lobectomy showed better survival outcomes than sublobar resection. Our findings require further validation by randomized controlled trial (RCT) or other evidence.

The Efficacy and Safety of Wedge Resection for Peripheral Stage IA Lung Adenocarcinoma: a Real-World Study Based on a Single Center

The Surgical Management of Early-Stage Lung Adenocarcinoma: is Wedge Resection Effective?

Extent of surgical resection for radiologically subsolid T1N0 invasive lung adenocarcinoma: When is a wedge resection acceptable?

Survival and Long-Term Cause-Specific Mortality Associated with Stage IA Lung Adenocarcinoma after Wedge Resection Vs. Segmentectomy: A Population-Based Propensity Score Matching and Competing Risk Analysis

Survival Rates after Lobectomy, Segmentectomy, and Wedge Resection for Non-Small Cell Lung Cancer.

Predictors of Upstage and Treatment Strategies for Stage IA Lung Cancers after Sublobar Resection for Adenocarcinoma in Situ and Minimally Invasive Adenocarcinoma

Sublobar Resections for Small-Sized Stage Ia Lung Adenocarcinoma: a Sino-Japanese Multicenter Study

Intentional wedge resection versus segmentectomy for ≤2 cm Ground-Glass-Opacity-Dominant Non-Small cell lung cancer: a Real-World study using inverse probability of treatment weighting

Surgery for Pre- and Minimally Invasive Lung Adenocarcinoma.

Effectiveness and Safety of Systematic and Selective Lymphadenectomies in Chinese Patients with Non-Small Cell Lung Cancer Who Received Sublobar Resection.

STS Database Analysis: Comparing Sublobar Techniques in Stage IA Lung Cancer

Predicting the Recurrence Risk Factors and Clinical Outcomes of Peripheral Pulmonary Adenocarcinoma ≤3 Cm with Wedge Resection

Prognostic Significance of Postoperative Longitudinal Change of Serum Carcinoembryonic Antigen Level in Patients with Stage I Lung Adenocarcinoma Completely Resected by Single-Port Video-Assisted Thoracic Surgery: a Retrospective Study

Selection of the surgical approach for patients with cStage IA lung squamous cell carcinoma: A population-based propensity score matching analysis

Sublobar Resection for Lung Adenocarcinoma Less Than 2 Cm Containing Solid or Micropapillary Components Radiologically Presented As Consolidation-to-tumor Ratio (CTR) ≤0.25 [Ground-Glass Opacity (GGO)]

Treatment Modality for Stage IB Peripheral Non-Small Cell Lung Cancer With Visceral Pleural Invasion and ≤3 cm in Size

Sublobar Resection for Adenocarcinoma in Situ and Minimally Invasive Adenocarcinoma Diagnosed by Intraoperative Frozen Section (ECTOP-1019): a Study Protocol of Prospective, Single-Arm, Multicenter, Phase III Study

Optimal Margins for Early Stage Peripheral Lung Adenocarcinoma Resection

Protocol for a Single-Arm, Multicenter, Prospective, Confirmatory Phase III Trial of Wedge Resection for Invasive Ground Glass Opacity-Featured Lung Cancer with a Size ≤2 Cm and a Consolidation Tumor Ratio Between 0.25 and 0.5 (ECTOP-1020 Study)

Ten-year follow-up of lung cancer patients with resected adenocarcinoma in situ or minimally invasive adenocarcinoma: Wedge resection is curative

The Impact of Margins on Outcomes After Wedge Resection for Stage I Non-Small Cell Lung Cancer